Cervical Cancer in Latin America & the Caribbean Silvana Luciani
PRESENTATION OVERVIEW
HOW CERVICAL CANCER DEVELOPS
EMOGRAPHIC, SOCIOECONOMIC & MORTALITY INDICATORS
OPULATION
URBAN POPULATION
(thousands)
USA: 314,659 LAC: 582,390
USA: 82% LAC: 78.8%
MATERNAL TALITY RATIO
INFANT MORTALITY RA
(100,000)
(100,000)
USA: 13.3 LAC: 87.4
USA: 6.7 LAC: 18.7
GROSS NATIONAL INCOME USA: 46,040
IN LATIN AMERICAN AND THE CARIBBEAN Most frequent cancer among women
200,000,000 women
72,000 new cases
33,000 deaths
AGE-STANDARDIZED INCIDENCE RATES per 100,000 women/year
AGE-STANDARDIZED MORTALITY RATES per 100,000 women/year
PV Prevalence in Selected Countrie HPV PREVALENCE (%) AMONG WOMEN WITH NORMAL CYTOLOGY
HPV GENOTYPES IN LAC
HPV TYPES
TEN MOST FREQUENT HPV TYPES (%) AMONG WOMEN WITH CERVICAL CANCER
CERVICAL CANCER IN LATIN AMERICAN AND THE CARIBBEAN
Why such a difference in cervical cancer between LAC a developed countries? PROGRAM ORGANIZATION
SCREENING TECHNOLOGY
FACTORS ASSOCIAT WITH WOMEN
PREVENTION PROGRAMS
HPV VACCINES NEW SCREENING TESTS HPV DNA Tests, VIA
SCREEN & TREAT APPROACH
AMERICAN HEALTH ORGANIZATION´s W IN CERVICAL CANCER PREVENTION AND CONTROL
POLICY & ADVOCACY
PROGRAM SUPPORT
OPERATIONAL RESEAR
CERVICAL CANCER PREVENTION AND CONTROL
To improve capacity for comprehensive cervical cance prevention and control Health education Screening Pre-cancer treatment
Treatment & Palliative Car
HPV vaccine introduction
CONCLUSIONS
mprehensive, integrated approach to cervical cancer vention and control urgently needed in LAC
V vaccine price is the largest barrier to its introduction
dence and tools are available to improve effectiveness vical cancer programs
ACKNOWLEDGEMENTS
ernando Amado Haydee Padilla Jon Andrus
Macarena Perez Daniel Frade Elisa Prieto
Miguel Gonzales
Cuauhtemoc Ru
arbara Jauregui Mario Valcarcel
Marcia Moreira
Enrique Vasquez Merle Lewis Pan American